Structure-activity relationships of inhibitors derived from 3-amidinophenylalanine.

Thrombin is the key enzyme in coagulation and its inhibitors are of therapeutic interest since they are potential anticoagulants. The most potent inhibitor of the benzamidine type is N alpha-(2-naphthylsulfonyl-glycyl)-4-amidinophenylalanine piperidide (NAPAP). However, NAPAP and other substances designed so far do not fulfill the pharmacological requirements. The goal of designing new compounds was to obtain potent inhibitors with improved pharmacokinetic properties, such as absorption after oral application and a sustained elimination. Novel derivatives of 3-amidinophenylalanine as key building block were synthesized. The amidino moiety and both the N alpha- and the C-terminal substituents were widely varied. Some of the newly synthesized compounds are potent inhibitors of thrombin and exert improved pharmacokinetic properties.

[1]  H Brandstetter,et al.  Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics. , 1992, Journal of molecular biology.

[2]  F. Markwardt,et al.  Nα-aryisulfonyl-ω-(4-amidinophenyl)-α-aminoalkylcarboxylic acid amides - novel selective inhibitors of thrombin , 1980 .

[3]  M. Dixon.  The determination of enzyme inhibitor constants. , 1953, The Biochemical journal.

[4]  D. Turk,et al.  Crystallographic determination of thrombin complexes with small synthetic inhibitors as a starting point for the receptor-based design of antithrombotics. , 1993, Seminars in thrombosis and hemostasis.

[5]  J. Stürzebecher,et al.  Cyclic amides of N alpha-arylsulfonylaminoacylated 4-amidinophenylalanine--tight binding inhibitors of thrombin. , 1983, Thrombosis research.

[6]  D. Turk,et al.  The refined 1.9‐Å X‐ray crystal structure of d‐Phe‐Pro‐Arg chloromethylketone‐inhibited human α‐thrombin: Structure analysis, overall structure, electrostatic properties, detailed active‐site geometry, and structure‐function relationships , 1992, Protein science : a publication of the Protein Society.

[7]  D. Turk,et al.  Geometry of binding of the N alpha-tosylated piperidides of m-amidino-, p-amidino- and p-guanidino phenylalanine to thrombin and trypsin. X-ray crystal structures of their trypsin complexes and modeling of their thrombin complexes. , 1991, FEBS letters.

[8]  D. Turk,et al.  Geometry of binding of the benzamidine- and arginine-based inhibitors Nα-(2-naphthyl-sulphonyl-glycyl)-dl-p-amidinophenylalanyl-piperidine (NAPAP) and (2R,4R)-4-methyl-1-[Nα-(3-methyl-1,2,3,4-tetrahydro-8-quinolinesulphonyl)-l-arginyl]-2-piperidine carboxylic acid (MQPA) to human α-thrombin , 1990 .

[9]  C. Ehrhardt,et al.  Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile. , 1993, Trends in pharmacological sciences.

[10]  J. Stürzebecher,et al.  Synthetic inhibitors of bovine factor Xa and thrombin comparison of their anticoagulant efficiency. , 1989, Thrombosis research.

[11]  J. Powers,et al.  Synthetic Substrates and Inhibitors of Thrombin , 1992 .